Verisk Analytics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter revenues of $809.0 million and net income of $219.2 million.
Vistance Networks, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting net income of $1,030.6 million for the third quarter and $6,833.7 million for the nine months ended …
REGENXBIO Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission for the period ended September 30, 2026, disclosing share count, filing status, and key operational and regulatory risk factors as of November 5, 2026.
C4 Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing operational details, risk factors, and share count information for the third quarter.
Latigo Biotherapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
Vistance Networks, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing a new $100 million share repurchase authorization and the release of its third-quarter 2026 financial results.
Dyne Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
ConocoPhillips filed a Form 8-K on November 5, 2026, disclosing its financial and operating results for the quarter ended September 30, 2026, through a press release and supplemental financial information furnished as exhibits.
Cogent Communications Holdings, Inc. filed its third-quarter 2026 earnings disclosure on November 5, 2026, reporting service revenue of $231.2 million for the three months ended September 30, 2026, alongside debt repurchases and two non-binding letters of intent to sell four data centers.
Ceragon Networks Ltd. (NASDAQ:CRNT) reported its financial results for the third quarter ended September 30, 2026, via a press release filed on November 5, 2026, disclosing revenue growth of 11.7% year-over-year and positive operating cash flow of $14.1 million.